Table 2.
Variable | Odds ratio | 95% CI | p value |
---|---|---|---|
Age | 0.95 | 0.85 – 1.07 | 0.402 |
Male (vs. female ) | 1.34 | 0.77 – 2.33 | 0.299 |
Ethnicity (vs. White) | |||
African American | 0.31 | 0.10 – 1.01 | 0.052 |
Other ethnicity | 1.33 | 0.52 – 3.41 | 0.549 |
School enrollment (vs. not in school) | 0.75 | 0.41 – 1.37 | 0.345 |
Treatment history (vs. never in treatment) | 0.83 | 0.43 – 1.63 | 0.591 |
Depressive symptoms (BDI scores ‘≥20’ vs. ‘<20’) | 2.15 | 1.04 – 4.44 | 0.039 |
Marijuana use past 30 days (vs. 0 days) | |||
> 20 days | 2.07 | 0.84 – 5.12 | 0.114 |
1–20 days | 1.54 | 0.60 – 3.95 | 0.365 |
Drunk past 30 days (vs. 0 days) | |||
10 or more days | 1.32 | 0.55 – 3.12 | 0.535 |
1–9 days | 0.89 | 0.40 – 1.97 | 0.766 |
Other drug use past 30 days (vs. no use) | |||
Heroin | 2.22 | 0.53 – 9.24 | 0.275 |
Cocaine | 1.48 | 0.80 – 2.70 | 0.210 |
Methamphetamine | 0.71 | 0.29 – 1.71 | 0.440 |
Ketamine | 0.75 | 0.34 – 1.66 | 0.472 |
Prescription tranquilizers | 6.43 | 3.36 – 12.31 | <0.001 |
Prescription stimulants | 2.90 | 1.33 – 6.32 | 0.007 |
LSD and psilocybin | 2.02 | 1.03 – 3.94 | 0.040 |
Inhalants | 2.26 | 1.01 - 5.06 | 0.048 |
Lifetime MDMA use (vs. 1–10 occasions) | |||
> 50 occasions | 0.77 | 0.33 – 1.82 | 0.551 |
21–50 occasions | 1.95 | 0.96 – 3.97 | 0.065 |
11–20 occasions | 1.20 | 0.59 – 2.43 | 0.617 |
Hosmer-Lemeshow Test: X2 =5.42, df=8, p=0.712